» Articles » PMID: 27826624

Mesenchymal Stem Cells Derived from Normal Gingival Tissue Inhibit the Proliferation of Oral Cancer Cells in Vitro and in Vivo

Overview
Journal Int J Oncol
Specialty Oncology
Date 2016 Nov 10
PMID 27826624
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The interplay between tumor cells and mesenchymal stem cells (MSCs) within tumor microenvironment plays a significant role in tumor development, and thus might be exploited for therapeutic intervention. In this study, we isolated MSCs from normal gingival tissue (GMSCs), and detected the effect of GMSCs on oral cancer cells via direct co-culture and indirect co-culture systems. The cell proliferation assay of direct co-culture showed that GMSCs could inhibit the growth of oral cancer cells. Conditioned medium derived from GMSCs (GMSCs-CM) also exerted an anticancer effect, which indicates that soluble factors in GMSCs-CM played a dominant role in GMSCs-induced cancer cell growth inhibition. To investigate the mechanism, we performed apoptosis assay by flow cytometry, and confirmed that cancer cell apoptosis induced by GMSCs could be a reason for the effect of GMSCs on the growth of oral cancer cells. Western blotting also confirmed that GMSCs could upregulate expression of pro-apoptotic genes including p-JNK, cleaved PARP, cleaved caspase-3, Bax expression and downregulate proliferation- and anti-apoptosis-related gene expression such as p-ERK1/2, Bcl-2, CDK4, cyclin D1, PCNA and survivin. Importantly, the inhibitory effect of GMSCs on cancer cells can partially be restored by blockade of JNK pathway. Moreover, animal studies showed that GMSCs exerted an anticancer effect after oral cancer cells and GMSCs were co-injected with oral cancer cells. Taken together, our data suggest that GMSCs can suppress oral cancer cell growth in vitro and in vivo via altering the surrounding microenvironment of oral cancer cells, which indicates that GMSCs have a potential use in the management of oral dysplasia and oral cancer in future.

Citing Articles

Establishment of subcutaneous transplantation platform for delivering induced pluripotent stem cell-derived insulin-producing cells.

Tran H, Rodprasert W, Padeta I, Oontawee S, Purbantoro S, Thongsit A PLoS One. 2025; 20(1):e0318204.

PMID: 39883721 PMC: 11781742. DOI: 10.1371/journal.pone.0318204.


Role of Mesenchymal Stem/Stromal Cells in Head and Neck Cancer-Regulatory Mechanisms of Tumorigenic and Immune Activity, Chemotherapy Resistance, and Therapeutic Benefits of Stromal Cell-Based Pharmacological Strategies.

Starska-Kowarska K Cells. 2024; 13(15.

PMID: 39120301 PMC: 11311692. DOI: 10.3390/cells13151270.


Gingival mesenchymal stem cells: Biological properties and therapeutic applications.

Peng Y, Jaar J, Tran S J Oral Biol Craniofac Res. 2024; 14(5):547-569.

PMID: 39108352 PMC: 11301388. DOI: 10.1016/j.jobcr.2024.07.003.


Analogies and Differences Between Dental Stem Cells: Focus on Secretome in Combination with Scaffolds in Neurological Disorders.

Santilli F, Fabrizi J, Santacroce C, Caissutti D, Spinello Z, Candelise N Stem Cell Rev Rep. 2023; 20(1):159-174.

PMID: 37962698 PMC: 10799818. DOI: 10.1007/s12015-023-10652-9.


The Therapeutic Effects of Mesenchymal Stem Cells and their Secretome on Oral Squamous Cell Carcinoma.

Ataei A, Azizi M, Hajisadeghi S, Madani M, Khorami M, Hassantash S Curr Mol Med. 2023; 24(10):1195-1207.

PMID: 37366360 DOI: 10.2174/1566524023666230627151809.